These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 23831622)
1. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Takikawa T; Masamune A; Hamada S; Nakano E; Yoshida N; Shimosegawa T Biochem Biophys Res Commun; 2013 Aug; 437(3):433-9. PubMed ID: 23831622 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Kikuta K; Masamune A; Watanabe T; Ariga H; Itoh H; Hamada S; Satoh K; Egawa S; Unno M; Shimosegawa T Biochem Biophys Res Commun; 2010 Dec; 403(3-4):380-4. PubMed ID: 21081113 [TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells. Masamune A; Yoshida N; Hamada S; Takikawa T; Nabeshima T; Shimosegawa T Biochem Biophys Res Commun; 2018 Jan; 495(1):71-77. PubMed ID: 29111329 [TBL] [Abstract][Full Text] [Related]
4. Alteration of the microRNA expression profile during the activation of pancreatic stellate cells. Masamune A; Nakano E; Hamada S; Takikawa T; Yoshida N; Shimosegawa T Scand J Gastroenterol; 2014 Mar; 49(3):323-31. PubMed ID: 24404812 [TBL] [Abstract][Full Text] [Related]
5. IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells. Hamada S; Masamune A; Yoshida N; Takikawa T; Shimosegawa T Dig Dis Sci; 2016 Jun; 61(6):1561-71. PubMed ID: 26738736 [TBL] [Abstract][Full Text] [Related]
6. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547 [TBL] [Abstract][Full Text] [Related]
7. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells. Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor. Kuninty PR; Bojmar L; Tjomsland V; Larsson M; Storm G; Östman A; Sandström P; Prakash J Oncotarget; 2016 Mar; 7(13):16396-408. PubMed ID: 26918939 [TBL] [Abstract][Full Text] [Related]
9. Exosomes Derived From Pancreatic Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer Cells. Takikawa T; Masamune A; Yoshida N; Hamada S; Kogure T; Shimosegawa T Pancreas; 2017 Jan; 46(1):19-27. PubMed ID: 27841793 [TBL] [Abstract][Full Text] [Related]
10. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway. Cao W; Zeng Z; He Z; Lei S Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966 [TBL] [Abstract][Full Text] [Related]
11. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment. Dey S; Liu S; Factora TD; Taleb S; Riverahernandez P; Udari L; Zhong X; Wan J; Kota J BMC Cancer; 2020 Jul; 20(1):651. PubMed ID: 32660466 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760 [No Abstract] [Full Text] [Related]
13. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer. Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197 [TBL] [Abstract][Full Text] [Related]
14. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor. Nam S; Khawar IA; Park JK; Chang S; Kuh HJ Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress plays a role in high glucose-induced activation of pancreatic stellate cells. Ryu GR; Lee E; Chun HJ; Yoon KH; Ko SH; Ahn YB; Song KH Biochem Biophys Res Commun; 2013 Sep; 439(2):258-63. PubMed ID: 23973482 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. Eguchi D; Ikenaga N; Ohuchida K; Kozono S; Cui L; Fujiwara K; Fujino M; Ohtsuka T; Mizumoto K; Tanaka M J Surg Res; 2013 May; 181(2):225-33. PubMed ID: 22795353 [TBL] [Abstract][Full Text] [Related]
17. miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro. Shen J; Wan R; Hu G; Yang L; Xiong J; Wang F; Shen J; He S; Guo X; Ni J; Guo C; Wang X Pancreatology; 2012; 12(2):91-9. PubMed ID: 22487517 [TBL] [Abstract][Full Text] [Related]
18. Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility. Sada M; Ohuchida K; Horioka K; Okumura T; Moriyama T; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Nakamura M Cancer Lett; 2016 Mar; 372(2):210-8. PubMed ID: 26805763 [TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 in pancreatic stellate cells promotes the progression of pancreatic cancer. Yoshida N; Masamune A; Hamada S; Kikuta K; Takikawa T; Motoi F; Unno M; Shimosegawa T Cancer Lett; 2017 Apr; 390():103-114. PubMed ID: 28093281 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis. Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]